Rheumatologie-Leitlinien
50 aktuelle Rheumatologie-Leitlinien von nationalen Behörden, europäischen Fachgesellschaften und HTA-Institutionen, über 11 Quellgruppen. eUvidence verankert Rheumatologie-Antworten an diesen Leitlinien; jeder Eintrag verlinkt auf die eigene Seite der herausgebenden Institution.
Europäische Fachgesellschaften· 13
- EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
EULAR · European Alliance of Associations for Rheumatology · 2025 · recommendation
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the treatment of systemic sclerosis: 2023 update
EULAR · European Alliance of Associations for Rheumatology · 2024 · recommendation
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2023 · recommendation
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
EULAR · European Alliance of Associations for Rheumatology · 2023 · recommendation
- EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
EULAR · European Alliance of Associations for Rheumatology · 2020 · recommendation
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
EULAR · European Alliance of Associations for Rheumatology · 2020 · recommendation
- EULAR recommendations for the management of antiphospholipid syndrome in adults
EULAR · European Alliance of Associations for Rheumatology · 2019 · recommendation
- 2018 update of the EULAR recommendations for the management of hand osteoarthritis
EULAR · European Alliance of Associations for Rheumatology · 2019 · recommendation
- 2016 updated EULAR evidence-based recommendations for the management of gout
EULAR · European Alliance of Associations for Rheumatology · 2017 · recommendation
- 2015 Recommendations for the management of polymyalgia rheumatica: a EULAR/ACR collaborative initiative
EULAR · European Alliance of Associations for Rheumatology · 2015 · recommendation
Österreich· 1
- Osteoporosis - definition, risk assessment, diagnosis, prevention and treatment (Update 2024)
OEGKM · Osterreichische Gesellschaft fuer Knochen- und Mineralstoffwechsel · 2024
Dänemark· 1
- Osteoporosis in Postmenopausal Women and Men Over 60 in General Practice
DSAM · Dansk Selskab for Almen Medicin · 2024
Finnland· 1
- Rheumatoid Arthritis (RA)
Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Society for Rheumatology · 2015
Frankreich· 6
- 2024 Update of the French Society for Rheumatology Recommendations for the Diagnosis and Management of People with Rheumatoid Arthritis
SFR · Societe Francaise de Rhumatologie · 2024 · recommendation
- French Society for Rheumatology Recommendations for the Everyday Management of Patients with Polymyalgia Rheumatica
SFR · Societe Francaise de Rhumatologie · 2024 · recommendation
- 2022 Update of the SFR Recommendations for the Everyday Management of Patients with Spondyloarthritis, Including Psoriatic Arthritis
SFR · Societe Francaise de Rhumatologie · 2022 · recommendation
- French Recommendations for the Management and Treatment of Male Osteoporosis
SFR · Societe Francaise de Rhumatologie · 2021 · recommendation
- French Society for Rheumatology Recommendations for the Management of Gout: Urate-Lowering Therapy
SFR · Societe Francaise de Rhumatologie · 2020 · recommendation
- 2018 Update of French Recommendations for the Treatment of Postmenopausal Osteoporosis
SFR · Societe Francaise de Rhumatologie · 2018 · recommendation
Deutschland· 7
- Management of Systemic Lupus Erythematosus (incl. Secondary Antiphospholipid Syndrome, Family Planning and Pregnancy)
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Treatment of Polymyalgia Rheumatica (Update 2024)
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Diagnosis and Treatment of Systemic Sclerosis
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2025
- Diagnosis and Treatment of Gout
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2024
- Diagnosis and Treatment of ANCA-Associated Vasculitides
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2024
- Diagnosis and Treatment of Adult-Onset Still's Disease
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2023
- Axial Spondyloarthritis including Ankylosing Spondylitis and Early Forms
DGRh · Deutsche Gesellschaft fuer Rheumatologie · 2019
Italien· 1
- Diagnosis and Treatment of Large-Vessel Vasculitis
SIR · Societa Italiana di Reumatologia · 2021
Niederlande· 7
- Rheumatoid Arthritis
FMS · Federatie Medisch Specialisten · 2026
- Treatment of Axial Spondyloarthritis
FMS · Federatie Medisch Specialisten · 2025
- Pharmacological Treatment of Psoriatic Arthritis
FMS · Federatie Medisch Specialisten · 2024
- Diagnosis and Treatment of Gout in Secondary Care
FMS · Federatie Medisch Specialisten · 2024
- Pharmacological Treatment and Monitoring of Systemic Lupus Erythematosus
FMS · Federatie Medisch Specialisten · 2023
- Osteoporosis and Fracture Prevention
FMS · Federatie Medisch Specialisten · 2022
- Conservative Treatment of Osteoarthritis of the Hip or Knee
FMS · Federatie Medisch Specialisten · 2019
Spanien· 3
- Clinical Practice Guideline for the Management of Patients with Rheumatoid Arthritis
SER · Sociedad Espanola de Reumatologia · 2025
- Clinical Practice Guideline for the Treatment of Axial Spondyloarthritis and Psoriatic Arthritis (ESPOGUIA)
SER · Sociedad Espanola de Reumatologia · 2025
- Clinical Practice Guidelines on Postmenopausal, Glucocorticoid-Induced and Male Osteoporosis (2022 Update)
SEIOMM · Sociedad Espanola de Investigacion Osea y del Metabolismo Mineral · 2022
Schweden· 1
- National Guidelines for Musculoskeletal Diseases - Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Osteoarthritis and Osteoporosis - Support for Governance and Management
Socialstyrelsen · National Board of Health and Welfare · 2021
Vereinigtes Königreich· 9
- The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
BSR · British Society for Rheumatology · 2025
- Osteoarthritis in over 16s: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2022
- Gout: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2022
- Rheumatoid arthritis in adults: management
NICE · National Institute for Health and Care Excellence · 2020
- British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
BSR · British Society for Rheumatology · 2020
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
BSR · British Society for Rheumatology · 2018
- Spondyloarthritis in over 16s: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2017
- Osteoporosis: assessing the risk of fragility fracture
NICE · National Institute for Health and Care Excellence · 2017
- BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
BSR · British Society for Rheumatology · 2017
Suchen Sie ein bestimmtes Land? Österreich, Dänemark, Finnland, Frankreich, Deutschland, Italien.